A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine
Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...
Үндсэн зохиолчид: | Sajjad Desai, K. Anil, Anirudha Vyankatesh Potey, Y. Sindhu, Silvia Grappi, Giulia Lapini, Satyaprasad Manney, Parikshit Tyagi, Emanuele Montomoli, Cyrus S. Poonawalla, Prasad S. Kulkarni |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Nature Portfolio
2022-12-01
|
Цуврал: | npj Vaccines |
Онлайн хандалт: | https://doi.org/10.1038/s41541-022-00595-6 |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
A cross-sectional study to assess the incompatible dietary behavior of patients suffering from skin diseases: A pilot study
-н: Meghana Kulkarni, зэрэг
Хэвлэсэн: (2016-04-01) -
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
-н: Elena Gianchecchi, зэрэг
Хэвлэсэн: (2022-02-01) -
Electron transport chain capacity expands yellow fever vaccine immunogenicity
-н: Darren ZL Mok, зэрэг
Хэвлэсэн: (2024-05-01) -
Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease
-н: Jesiree Iglésias Quadros Distenhreft, зэрэг
Хэвлэсэн: (2024-08-01) -
Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice
-н: Ji Ma, зэрэг
Хэвлэсэн: (2021-01-01)